By Asia Analytica / The Edge Financial Daily | July 22, 2016 : 10:46 AM MYT
This article first appeared in The Edge Financial Daily, on July 22, 2016.
TMC Life Sciences Bhd (+ve)
SHARES in TMC Life (fundamental: 1.75/3; valuation: 1.1/3) fell two sen or 2.25% to 87 sen with 5.6 million shares traded yesterday. In comparison, it has a 200-day average volume of 1.05 million shares. Since July began, TMC Life has been picked up three times by our proprietary algorithm. Year to date, its share price has increased by 28.57%.
Yesterday, the company and its Singapore associate Thomson Medical announced that they have inked a memorandum of understanding (MoU) with UK-based Cell Therapy Ltd to collaborate on research and development in the biomedical and health sciences space.The MoU lasts for five years, and it forms the basis of consensus for them to examine the feasibility of the project until a definitive agreement entered into by them.
On Tuesday, TMC Life announced a MoU with Thomson Medical and University College Dublin to set up a health sciences training and education platform in Malaysia and Singapore.